PMID- 22568145
OWN - NLM
STAT- MEDLINE
DCOM- 20120802
LR  - 20120508
IS  - 0047-1852 (Print)
IS  - 0047-1852 (Linking)
VI  - 70
IP  - 4
DP  - 2012 Apr
TI  - [Immunoglobulin preparations].
PG  - 629-34
AB  - Intravenous immunoglobulin (IVIG) preparation contains the antibodies to protect 
      against the infectious agents that cause various diseases. IVIGs have become 
      increasingly important both as replacement therapy in primary and acquired 
      humoral immunodeficiency and as an immunomodulatory therapy in autoimmune 
      diseases. At present, the use of IVIGs for prevention against viral infections 
      has been proven beneficial only for a limited number of infections such as 
      measles, varicella, hepatitis A, hepatitis B. The addition of high-dose IVIG to 
      ganciclovir appears to be useful for treatment of Cytomegalovirus pneumonia 
      following bone marrow transplantation.
FAU - Ono, Yasuo
AU  - Ono Y
AD  - Department of Microbiology and Immunology, Teikyo University School of Medicine.
LA  - jpn
PT  - English Abstract
PT  - Journal Article
PT  - Review
PL  - Japan
TA  - Nihon Rinsho
JT  - Nihon rinsho. Japanese journal of clinical medicine
JID - 0420546
RN  - 0 (Antiviral Agents)
RN  - 0 (Immunoglobulins, Intravenous)
SB  - IM
MH  - Antiviral Agents/administration & dosage
MH  - Drug Therapy, Combination
MH  - Humans
MH  - Immunoglobulins, Intravenous/administration & dosage/*therapeutic use
MH  - Virus Diseases/*drug therapy
EDAT- 2012/05/10 06:00
MHDA- 2012/08/03 06:00
CRDT- 2012/05/10 06:00
PHST- 2012/05/10 06:00 [entrez]
PHST- 2012/05/10 06:00 [pubmed]
PHST- 2012/08/03 06:00 [medline]
PST - ppublish
SO  - Nihon Rinsho. 2012 Apr;70(4):629-34.